Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Byung Hee Yoo, Ph.D.

Profile Picture

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Savan NA, Saavedra PV, Halim A, Yuzbasiyan-Gurkan V, Wang P, Yoo B, Kiupel M, Sempere L, Medarova Z, Moore A. Case report: MicroRNA-10b as a therapeutic target in feline metastatic mammary carcinoma and its implications for human clinical trials. Front Oncol. 2022; 12:959630. PMID: 36387245; PMCID: PMC9643803.
  2. Smith ES, Whitty E, Yoo B, Moore A, Sempere LF, Medarova Z. Clinical Applications of Short Non-Coding RNA-Based Therapies in the Era of Precision Medicine. Cancers (Basel). 2022 Mar 21; 14(6). PMID: 35326738; PMCID: PMC8946086.
    Citations: 2     
  3. Le Fur M, Ross A, Pantazopoulos P, Rotile N, Zhou I, Caravan P, Medarova Z, Yoo B. Radiolabeling and PET-MRI microdosing of the experimental cancer therapeutic, MN-anti-miR10b, demonstrates delivery to metastatic lesions in a murine model of metastatic breast cancer. Cancer Nanotechnol. 2021; 12(1). PMID: 34531932; PMCID: PMC8442631.
  4. Yoo B, Ross A, Pantazopoulos P, Medarova Z. MiRNA10b-directed nanotherapy effectively targets brain metastases from breast cancer. Sci Rep. 2021 02 02; 11(1):2844. PMID: 33531596; PMCID: PMC7854676.
    Citations: 1     Fields:    Translation:HumansAnimalsCells
  5. Medarova Z, Pantazopoulos P, Yoo B. Screening of potential miRNA therapeutics for the prevention of multi-drug resistance in cancer cells. Sci Rep. 2020 02 06; 10(1):1970. PMID: 32029822.
    Citations: 11     Fields:    Translation:HumansCells
  6. Yoo B, Meka N, Sheedy P, Billig AM, Pantazopoulos P, Medarova Z. MicroRNA-710 regulates multiple pathways of carcinogenesis in murine metastatic breast cancer. PLoS One. 2019; 14(12):e0226356. PMID: 31834924; PMCID: PMC6910689.
    Citations: 3     Fields:    Translation:AnimalsCells
  7. Yoo B, Jordan VC, Sheedy P, Billig AM, Ross A, Pantazopoulos P, Medarova Z. RNAi-Mediated PD-L1 Inhibition for Pancreatic Cancer Immunotherapy. Sci Rep. 2019 03 18; 9(1):4712. PMID: 30886310.
    Citations: 13     Fields:    Translation:HumansAnimalsCells
  8. Yoo B, Greninger P, Stein GT, Egan RK, McClanaghan J, Moore A, Benes CH, Medarova Z. Potent and selective effect of the mir-10b inhibitor MN-anti-mir10b in human cancer cells of diverse primary disease origin. PLoS One. 2018; 13(7):e0201046. PMID: 30028875; PMCID: PMC6054402.
    Citations: 5     Fields:    Translation:HumansAnimalsCells
  9. Yoo B, Fuchs BC, Medarova Z. New Directions in the Study and Treatment of Metastatic Cancer. Front Oncol. 2018; 8:258. PMID: 30042926; PMCID: PMC6048200.
    Citations: 8     
  10. Yoo B, Billig AM, Medarova Z. Guidelines for Rational Cancer Therapeutics. Front Oncol. 2017; 7:310. PMID: 29312885; PMCID: PMC5732930.
    Citations: 3     
  11. Yoo B, Kavishwar A, Wang P, Ross A, Pantazopoulos P, Dudley M, Moore A, Medarova Z. Therapy targeted to the metastatic niche is effective in a model of stage IV breast cancer. Sci Rep. 2017 03 21; 7:45060. PMID: 28322342.
    Citations: 21     Fields:    Translation:HumansAnimalsCells
  12. Wang P, Ross A, Yoo B, Yang J, Farrar C, Ran C, Pantazopoulos P, Medarova Z, Moore A. Magnetic resonance imaging of intra-pancreatic ductal nanoparticle delivery to islet cells. Diabetes Metab Res Rev. 2017 07; 33(5). PMID: 28032446.
    Citations:    Fields:    Translation:Animals
  13. Wang P, Yoo B, Sherman S, Mukherjee P, Ross A, Pantazopoulos P, Petkova V, Farrar C, Medarova Z, Moore A. Predictive imaging of chemotherapeutic response in a transgenic mouse model of pancreatic cancer. Int J Cancer. 2016 08 01; 139(3):712-8. PMID: 26996122; PMCID: PMC4925171.
    Citations: 7     Fields:    Translation:HumansAnimalsCells
  14. Yoo B, Kavishwar A, Ross A, Pantazopoulos P, Moore A, Medarova Z. In Vivo Detection of miRNA Expression in Tumors Using an Activatable Nanosensor. Mol Imaging Biol. 2016 Feb; 18(1):70-8. PMID: 25987466.
    Citations: 3     Fields:    Translation:HumansAnimalsCells
  15. Yoo B, Kavishwar A, Ross A, Wang P, Tabassum DP, Polyak K, Barteneva N, Petkova V, Pantazopoulos P, Tena A, Moore A, Medarova Z. Combining miR-10b-Targeted Nanotherapy with Low-Dose Doxorubicin Elicits Durable Regressions of Metastatic Breast Cancer. Cancer Res. 2015 Oct 15; 75(20):4407-15. PMID: 26359455; PMCID: PMC4609288.
    Citations: 36     Fields:    Translation:HumansAnimalsCells
  16. Yoo B, Ifediba MA, Ghosh S, Medarova Z, Moore A. Combination treatment with theranostic nanoparticles for glioblastoma sensitization to TMZ. Mol Imaging Biol. 2014 Oct; 16(5):680-9. PMID: 24696184.
    Citations: 10     Fields:    Translation:HumansAnimalsCells
  17. Hingorani DV, Yoo B, Bernstein AS, Pagel MD. Detecting enzyme activities with exogenous MRI contrast agents. Chemistry. 2014 Aug 04; 20(32):9840-50. PMID: 24990812.
    Citations: 11     Fields:    Translation:HumansAnimalsCells
  18. Yoo B, Ghosh SK, Kumar M, Moore A, Yigit MV, Medarova Z. Design of nanodrugs for miRNA targeting in tumor cells. J Biomed Nanotechnol. 2014 Jun; 10(6):1114-22. PMID: 24749405.
    Citations: 12     Fields:    Translation:HumansCells
  19. Tak WY, Yang JM, Kim BI, Baik SK, Cheon GJ, Byun KS, Kim DY, Yoo BC. A randomized, open-label study comparing low-dose clevudine plus adefovir combination therapy with clevudine monotherapy in naïve chronic hepatitis B patients. Hepatol Int. 2014 Jul; 8(3):375-81. PMID: 25101150.
    Citations: 4     Fields:    
  20. Yoo B, Sheth VR, Howison CM, Douglas MJ, Pineda CT, Maine EA, Baker AF, Pagel MD. Detection of in vivo enzyme activity with CatalyCEST MRI. Magn Reson Med. 2014 Mar; 71(3):1221-30. PMID: 23640714.
    Citations: 28     Fields:    Translation:AnimalsCells
  21. Wang P, Yoo B, Yang J, Zhang X, Ross A, Pantazopoulos P, Dai G, Moore A. GLP-1R-targeting magnetic nanoparticles for pancreatic islet imaging. Diabetes. 2014 May; 63(5):1465-74. PMID: 24458362; PMCID: PMC4178324.
    Citations: 22     Fields:    Translation:AnimalsCells
  22. Yoo B, Kavishwar A, Ghosh SK, Barteneva N, Yigit MV, Moore A, Medarova Z. Detection of miRNA expression in intact cells using activatable sensor oligonucleotides. Chem Biol. 2014 Feb 20; 21(2):199-204. PMID: 24440078.
    Citations: 8     Fields:    Translation:HumansCells
  23. Yoo B, Pagel MD. Lanthanide-mediated dephosphorylation used for peptide cleavage during solid phase peptide synthesis. Molecules. 2013 Apr 02; 18(4):3894-905. PMID: 23549296.
    Citations:    Fields:    Translation:Cells
  24. Ghosh SK, Uchida M, Yoo B, Ross AW, Gendler SJ, Gong J, Moore A, Medarova Z. Targeted imaging of breast tumor progression and therapeutic response in a human uMUC-1 expressing transgenic mouse model. Int J Cancer. 2013 Apr 15; 132(8):1860-7. PMID: 23015160.
    Citations: 13     Fields:    Translation:HumansAnimalsCells
  25. Kim YS, Lim HK, Rhim H, Lee MW, Choi D, Lee WJ, Paik SW, Koh KC, Lee JH, Choi MS, Gwak GY, Yoo BC. Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors. J Hepatol. 2013 Jan; 58(1):89-97. PMID: 23023009.
    Citations: 119     Fields:    Translation:Humans
  26. Josan JS, De Silva CR, Yoo B, Lynch RM, Pagel MD, Vagner J, Hruby VJ. Fluorescent and lanthanide labeling for ligand screens, assays, and imaging. Methods Mol Biol. 2011; 716:89-126. PMID: 21318902.
    Citations: 10     Fields:    Translation:HumansAnimalsCells
  27. Lee HS, Yoo BC, Lee KS, Kim JH, Um SH, Ryu SH, Lee YS, Kim YS, Yoo K, Han JY, Hwang JS, Kim TH, Yang JM, Lee HJ, Chon CY, Cho M, Han BH, Hwang SG, Byun KS, Chung YH, Cho SH, Koh KC, Kim BI, Kim HC, Paik SW, Lee MS, Yoo HW, Han CJ. Clevudine-induced viral response, associated with continued reduction of HBsAg titer, was durable after the withdrawal of therapy. J Gastroenterol. 2011 Mar; 46(3):410-4. PMID: 21181212.
    Citations: 6     Fields:    Translation:HumansCells
  28. Ali MM, Yoo B, Pagel MD. Tracking the relative in vivo pharmacokinetics of nanoparticles with PARACEST MRI. Mol Pharm. 2009 Sep-Oct; 6(5):1409-16. PMID: 19298054.
    Citations: 36     Fields:    Translation:HumansAnimalsCells
  29. Yoo B, Sheth VR, Pagel MD. An amine-derivatized, DOTA-loaded polymeric support for Fmoc Solid Phase Peptide Synthesis. Tetrahedron Lett. 2009 Aug 05; 50(31):4459-4462. PMID: 20161272.
    Citations: 14     Fields:    
  30. Liu G, Ali MM, Yoo B, Griswold MA, Tkach JA, Pagel MD. PARACEST MRI with improved temporal resolution. Magn Reson Med. 2009 Feb; 61(2):399-408. PMID: 19165903.
    Citations: 50     Fields:    Translation:HumansAnimalsCells
  31. Yoo B, Pagel MD. An overview of responsive MRI contrast agents for molecular imaging. Front Biosci. 2008 Jan 01; 13:1733-52. PMID: 17981664.
    Citations: 58     Fields:    Translation:HumansAnimalsCells
  32. Yoo BC, Kim JH, Kim TH, Koh KC, Um SH, Kim YS, Lee KS, Han BH, Chon CY, Han JY, Ryu SH, Kim HC, Byun KS, Hwang SG, Kim BI, Cho M, Yoo K, Lee HJ, Hwang JS, Kim YS, Lee YS, Choi SK, Lee YJ, Yang JM, Park JW, Lee MS, Kim DG, Chung YH, Cho SH, Choi JY, Kweon YO, Lee HY, Jeong SH, Yoo HW, Lee HS. Clevudine is highly efficacious in hepatitis B e antigen-negative chronic hepatitis B with durable off-therapy viral suppression. Hepatology. 2007 Oct; 46(4):1041-8. PMID: 17647293.
    Citations: 29     Fields:    Translation:HumansCells
  33. Yoo B, Raam MS, Rosenblum RM, Pagel MD. Enzyme-responsive PARACEST MRI contrast agents: a new biomedical imaging approach for studies of the proteasome. Contrast Media Mol Imaging. 2007 Jul; 2(4):189-98. PMID: 17712869.
    Citations: 41     Fields:    
  34. Yoo BC, Kim JH, Chung YH, Lee KS, Paik SW, Ryu SH, Han BH, Han JY, Byun KS, Cho M, Lee HJ, Kim TH, Cho SH, Park JW, Um SH, Hwang SG, Kim YS, Lee YJ, Chon CY, Kim BI, Lee YS, Yang JM, Kim HC, Hwang JS, Choi SK, Kweon YO, Jeong SH, Lee MS, Choi JY, Kim DG, Kim YS, Lee HY, Yoo K, Yoo HW, Lee HS. Twenty-four-week clevudine therapy showed potent and sustained antiviral activity in HBeAg-positive chronic hepatitis B. Hepatology. 2007 May; 45(5):1172-8. PMID: 17464992.
    Citations: 34     Fields:    Translation:HumansCTClinical Trials
  35. Yoo B, Pagel MD. Peptidyl molecular imaging contrast agents using a new solid-phase peptide synthesis approach. Bioconjug Chem. 2007 May-Jun; 18(3):903-11. PMID: 17330953; PMCID: PMC2584118.
    Citations: 7     Fields:    
  36. Yoo B, Pagel MD. A PARACEST MRI contrast agent to detect enzyme activity. J Am Chem Soc. 2006 Nov 01; 128(43):14032-3. PMID: 17061878.
    Citations: 78     Fields:    
  37. Byunghee Yoo, Mark D. Pagel. A facile synthesis of a-amino-DOTA as a versatile molecular imaging probe. Tetrahedron Lett. 2006; 47(41):7327-7330.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Yoo's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (175)
Co-Authors (6)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.